Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients
Abstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-10-01
|
Series: | Clinical Hypertension |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40885-017-0076-y |
id |
doaj-580e2830d5514f91bdfa0d793b9388f1 |
---|---|
record_format |
Article |
spelling |
doaj-580e2830d5514f91bdfa0d793b9388f12020-11-25T01:56:13ZengBMCClinical Hypertension2056-59092017-10-012311610.1186/s40885-017-0076-yClinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patientsTakashi Hitsumoto0Hitsumoto Medical ClinicAbstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact of skin AF on hs-cTnT in hypertensive patients, from the perspective of primary prevention of cardiovascular events. Methods In total, 457 outpatients on treatment for hypertension [182 men and 275 women; mean (± SD) age, 67 ± 13 y] and with no history of cardiovascular events were enrolled. Hs-cTnT levels and skin AF were measured using commercial devices, and relationships between hs-cTnT levels and various clinical parameters including skin AF were examined. Results Hs-cTnT was detected in 405 (88.6%) patients. Skin AF was significantly higher in patients with detectable hs-cTnT than in those without detectable hs-cTnT [2.6 ± 0.5 arbitrary units (AU) vs. 2.2 ± 0.5 AU, respectively, p < 0.001]. In patients with detectable hs-cTnT, there was a significantly positive correlation between skin AF and Log-hs-cTnT (r = 0.41, p < 0.001). Furthermore, multiple regression analysis revealed that skin AF was the strongest variable associated with Log-hs-cTnT as a subordinate factor (β = 0.30, p < 0.001). Conclusions The results of this study indicate that skin AF is an important determining factor for hs-cTnT elevation in hypertensive patients with no history of cardiovascular events.http://link.springer.com/article/10.1186/s40885-017-0076-ySkin autofluorescenceHigh-sensitivity troponin TOxidative stressArterial stiffnessHypertension |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Takashi Hitsumoto |
spellingShingle |
Takashi Hitsumoto Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients Clinical Hypertension Skin autofluorescence High-sensitivity troponin T Oxidative stress Arterial stiffness Hypertension |
author_facet |
Takashi Hitsumoto |
author_sort |
Takashi Hitsumoto |
title |
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients |
title_short |
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients |
title_full |
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients |
title_fullStr |
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients |
title_full_unstemmed |
Clinical impact of skin autofluorescence on high-sensitivity troponin T in hypertensive patients |
title_sort |
clinical impact of skin autofluorescence on high-sensitivity troponin t in hypertensive patients |
publisher |
BMC |
series |
Clinical Hypertension |
issn |
2056-5909 |
publishDate |
2017-10-01 |
description |
Abstract Background Recent studies have reported the importance of high-sensitivity troponin T (hs-cTnT) or skin autofluorescence (AF) as a cardiovascular risk factor. However, little is known about the relationship between these two markers. The aim of this study was to clarify the clinical impact of skin AF on hs-cTnT in hypertensive patients, from the perspective of primary prevention of cardiovascular events. Methods In total, 457 outpatients on treatment for hypertension [182 men and 275 women; mean (± SD) age, 67 ± 13 y] and with no history of cardiovascular events were enrolled. Hs-cTnT levels and skin AF were measured using commercial devices, and relationships between hs-cTnT levels and various clinical parameters including skin AF were examined. Results Hs-cTnT was detected in 405 (88.6%) patients. Skin AF was significantly higher in patients with detectable hs-cTnT than in those without detectable hs-cTnT [2.6 ± 0.5 arbitrary units (AU) vs. 2.2 ± 0.5 AU, respectively, p < 0.001]. In patients with detectable hs-cTnT, there was a significantly positive correlation between skin AF and Log-hs-cTnT (r = 0.41, p < 0.001). Furthermore, multiple regression analysis revealed that skin AF was the strongest variable associated with Log-hs-cTnT as a subordinate factor (β = 0.30, p < 0.001). Conclusions The results of this study indicate that skin AF is an important determining factor for hs-cTnT elevation in hypertensive patients with no history of cardiovascular events. |
topic |
Skin autofluorescence High-sensitivity troponin T Oxidative stress Arterial stiffness Hypertension |
url |
http://link.springer.com/article/10.1186/s40885-017-0076-y |
work_keys_str_mv |
AT takashihitsumoto clinicalimpactofskinautofluorescenceonhighsensitivitytroponintinhypertensivepatients |
_version_ |
1724980917248720896 |